Date | Source | Headline | |
---|---|---|---|
19th May 2010 | 7:00 am | RNS | Preliminary Results |
8th Apr 2010 | 9:26 am | RNS | Best Drug Development Company in Europe Award |
5th Jan 2010 | 3:00 pm | RNS | Additional Listing |
5th Jan 2010 | 7:00 am | RNS | ING take 4% stake in ImmuPharma plc |
3rd Dec 2009 | 7:00 am | RNS | R&D Symposium at the CNRS in Paris |
19th Nov 2009 | 7:00 am | RNS | Positive Final Lupuzor Trial Results |
19th Oct 2009 | 10:31 am | RNS | 'Best Technology 2009' Award at the AIM Awards |
9th Oct 2009 | 10:14 am | RNS | Appointment of Joint Broker |
29th Sep 2009 | 7:00 am | RNS | Interim Results |
21st Sep 2009 | 9:55 am | RNS | 8th Annual Bio Investor Forum |
17th Sep 2009 | 7:00 am | RNS | JMP Healthcare Focus Conference |
24th Jul 2009 | 12:12 pm | RNS | Result of AGM |
23rd Jul 2009 | 4:17 pm | RNS | Directors' Dealings |
30th Jun 2009 | 7:00 am | RNS | Annual Report and Accounts |
24th Jun 2009 | 7:00 am | RNS | Preliminary Results |
17th Jun 2009 | 7:00 am | RNS | Piper Jaffray Europe Conference |
23rd Mar 2009 | 7:00 am | RNS | Directors' Dealings |
4th Feb 2009 | 12:32 pm | RNS | Share Options |
2nd Feb 2009 | 2:33 pm | RNS | Cephalon license exercise |
30th Jan 2009 | 7:00 am | RNS | Successful trial results |
22nd Dec 2008 | 12:00 pm | RNS | further instalment of grant |
25th Nov 2008 | 7:00 am | RNS | Option Agreement with Cephalon |
12th Nov 2008 | 7:00 am | RNS | Grant Award |
21st Oct 2008 | 9:31 am | RNS | Patents Granted |
17th Oct 2008 | 4:22 pm | RNS | Additional Listing and Total Voting Rights |
25th Sep 2008 | 7:00 am | RNS | Interim Results |
5th Aug 2008 | 3:44 pm | RNS | AGM Result |
10th Jul 2008 | 7:00 am | RNS | Second Placing |
2nd Jul 2008 | 7:30 am | RNS | Toxicology study |
2nd Jul 2008 | 7:00 am | RNS | Fund Raising |
30th Jun 2008 | 3:00 pm | RNS | Annual Report and Accounts |
20th May 2008 | 7:00 am | RNS | Pre-clinical Data |
13th May 2008 | 6:00 am | RNS | Trademark Approval |
8th May 2008 | 7:00 am | RNS | Preliminary Results |
26th Feb 2008 | 7:00 am | RNS | Phase IIb Trial of IPP-201101 |
8th Jan 2008 | 7:00 am | RNS | Novel Drug Candidate |
18th Dec 2007 | 12:51 pm | RNS | Directors' Dealings |
6th Dec 2007 | 7:01 am | RNS | Initiation of Phase IIb trial |
16th Nov 2007 | 12:28 pm | RNS | Appointment of Nomad |
28th Sep 2007 | 7:02 am | RNS | Interim Results |
22nd Aug 2007 | 7:00 am | RNS | Compound Discovery |
20th Aug 2007 | 10:17 am | RNS | AIM Rule 26 |
13th Aug 2007 | 4:17 pm | RNS | Directors' Dealing |
6th Aug 2007 | 2:40 pm | RNS | Grant of Options |
10th Jul 2007 | 7:01 am | RNS | Pivotal phase II/III trial |
13th Jun 2007 | 2:00 pm | RNS | AGM and Board Update |
1st May 2007 | 7:02 am | RNS | Preliminary Results |
27th Apr 2007 | 4:02 pm | RNS | Board Appointment |
15th Feb 2007 | 7:01 am | RNS | Appointment of adviser |
7th Feb 2007 | 7:01 am | RNS | Board Changes |
Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.
To access our Live RNS you must confirm you are a private investor by using the button below.